BidaskClub Downgrades Mazor Robotics (MZOR) to Sell

Mazor Robotics (NASDAQ:MZOR) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Friday.

Several other brokerages have also issued reports on MZOR. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a research note on Wednesday, February 14th. Zacks Investment Research raised Mazor Robotics from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research note on Friday, February 2nd. Vetr raised Mazor Robotics from a “hold” rating to a “buy” rating and set a $66.27 target price on the stock in a research note on Thursday, March 1st. Finally, Barclays reissued a “sell” rating and issued a $36.00 target price on shares of Mazor Robotics in a research note on Tuesday, January 9th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $52.75.

Shares of MZOR opened at $55.48 on Friday. Mazor Robotics has a 12-month low of $29.55 and a 12-month high of $76.56. The firm has a market cap of $1,391.97, a PE ratio of -110.96 and a beta of 1.20.

Mazor Robotics (NASDAQ:MZOR) last issued its quarterly earnings results on Wednesday, February 14th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.09. Mazor Robotics had a negative return on equity of 14.03% and a negative net margin of 19.08%. The business had revenue of $19.15 million for the quarter, compared to analyst estimates of $19.00 million. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. The firm’s revenue for the quarter was up 36.4% compared to the same quarter last year. analysts forecast that Mazor Robotics will post 0.06 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in MZOR. JPMorgan Chase & Co. acquired a new position in Mazor Robotics in the third quarter valued at about $427,000. Ladenburg Thalmann Financial Services Inc. lifted its stake in Mazor Robotics by 107.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,811 shares of the medical instruments supplier’s stock valued at $188,000 after buying an additional 1,973 shares during the period. IFP Advisors Inc lifted its stake in Mazor Robotics by 87.2% in the fourth quarter. IFP Advisors Inc now owns 2,275 shares of the medical instruments supplier’s stock valued at $117,000 after buying an additional 1,060 shares during the period. Taylor Frigon Capital Management LLC acquired a new position in Mazor Robotics in the fourth quarter valued at about $1,965,000. Finally, SeaCrest Wealth Management LLC acquired a new position in Mazor Robotics in the fourth quarter valued at about $934,000. 24.55% of the stock is currently owned by hedge funds and other institutional investors.

About Mazor Robotics

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply